ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

A New Standard in Drug Testing: Intelligent Bio (NASDAQ: INBS) Delivering Cost-Efficiency, Rapid Results, and Employee Dignity more stocks inside…

NASDAQ: INBS) Delivering Cost-Efficiency, Rapid Results, and Employee Dignity more stocks inside…" src="https://www.abnewswire.com/uploads/1724854181.jpeg" alt="A New Standard in Drug Testing: Intelligent Bio (NASDAQ: INBS) Delivering Cost-Efficiency, Rapid Results, and Employee Dignity more stocks inside…" width="225" height="225">

As workplaces prioritize safety and efficiency, drug testing remains essential. Traditional methods, however, can be costly, slow, and invasive. Intelligent Bio Solutions Inc. (NASDAQ: INBS) is redefining this process with the INBS Drug Reader, a cutting-edge solution that sets a new standard for workplace drug testing.

Cost-Efficiency and Rapid Results

The INBS Drug Reader offers a cost-effective alternative to traditional drug tests, with each test priced at approximately $20. This affordability allows for more frequent testing, ensuring a safer work environment without the financial burden. Additionally, the device delivers results in just 10 minutes, far quicker than the days it takes for urine or hair tests. This rapid turnaround is crucial in industries like construction and logistics, where immediate decisions are often necessary.

Respect for Employee Dignity

One of the standout features of the INBS Drug Reader is its non-invasive approach. Unlike urine or hair tests, which can be uncomfortable and intrusive, the INBS Drug Reader uses a simple fingerprint scan to detect drug use. This method not only preserves employee dignity but also fosters a more positive workplace culture.

Portability and Tamper-Proof Design

The INBS Drug Reader is portable and tamper-proof, making it ideal for on-site testing and random drug testing policies. Its reliable and immediate results ensure that companies can maintain safety standards without disrupting operations.

By combining affordability, speed, respect for employees, and ease of use, the INBS Drug Reader is setting a new standard for workplace drug testing, helping companies create safer and more productive environments. For more information, visit www.intelligentbiosolutions.com

Also, here are seven standout undervalued companies, several under $1, demonstrating strong market trends, volume, and heightened awareness: 

BranchOut Food Inc. (NASDAQ: BOF) a food technology company, reported a remarkable 640% increase in net revenue for the first half of 2024, Net revenue surged to $2.83 million, signaling robust momentum for the year ahead. 

AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) an intellectual property (“IP”) focused technology company, announces the closing of the acquisition of Radical Clean Solutions Limited (“RCS”) a company which holds worldwide rights in the agriculture space. 

CS Diagnostics Group’s (OTC: FZRO) CS Protect-Hydrogel, used in radiation therapy to shield healthy tissue, was valued at over €960 million (equivalent to over $1 billion USD). This valuation aligns with a similar product Boston Scientific (NYSE: BSX) acquired for $500 million in 2018. The stock surged 178% in August 2024, rising from $0.32 to $0.89. 

Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE): Volume surges as the market responds positively to the new share structure, with shares rebounding from a low of $3 early last week to an intraday high of $10.50 and closing of $8.04 on Thursday August 22, 2024. 

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL): The exclusive U.S. distributor of BIDI® Stick and global distributor of VEEBA® through Philip Morris Products SA (NYSE: PM), trending towards the 52-week low undervalued, a fundamentally sound company worth a look at these levels.   

Signal Advance, Inc.’s (OTC: SIGL) Analog Guard® could prove a formidable defense against cybercrime and cyberterrorism globally. Yesterday the stock increased 30.57% on 10x average 30-day volume on Tuesday August 27, 2024. 

GD Culture Group Limited (NASDAQ: GDC): The stock skyrocketed over 400% this week, climbing from $1.66 to an intraday high of $12 closing at $6.02 on Tuesday August 27, 2024, driven by entering the livestream market through AI Catalysis and news on SyncWaveX. 

These companies are currently showing strong market trends, increased trading volumes, and growing investor awareness, making them compelling opportunities for value-focused investors.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.